Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 8:00 PM View:  | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 18-Nov-24 | Payment of Exercise | 4,558 | $102.89 | $468,973.00 | (6%) 72.19K to 67.63K | |
| 16-Sep-24 8:05 PM View: | Connelly Deirdre P Director | AVI Biopharma, Inc. (SRPT) | 12-Sep-24 | Grant | 2,842 | -- | -- | 100% 0 to 2.84K | |
| 05-Sep-24 8:00 PM View: | Behrens M Kathleen Director | AVI Biopharma, Inc. (SRPT) | 04-Sep-24 | Gift | 746 | -- | -- | (< 1%) 201.84K to 201.09K | |
| 03-Sep-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 30-Aug-24 | Private Sale | 5,985 | $137.36 | $822,100.00 | (15%) 39.93K to 33.95K | |
| 20-Aug-24 8:00 AM View: | Chambers Michael Andrew Director | AVI Biopharma, Inc. (SRPT) | 16-Aug-24 | Purchase | 37,038 | $133.80 | $4,955,730.00 | 15% 255.27K to 292.31K | |
| 08-Jul-24 8:00 PM View: | Behrens M Kathleen Director | AVI Biopharma, Inc. (SRPT) | 03-Jul-24 | Option Exercise | 15,000 | $13.90 | $208,500.00 | 8% 186.84K to 201.84K | |
| 25-Jun-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 25-Jun-24 | Option Exercise | 23,500 | $62.77 | $1,475,100.00 | 72% 32.59K to 56.09K | |
| 25-Jun-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 25-Jun-24 | Planned Option Sale | 29,750 | $161.62 | $4,808,040.00 | (53%) 56.09K to 26.34K | |
| 25-Jun-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 25-Jun-24 | Sale (Planned) | 3,898 | $163.23 | $636,270.00 | (18%) 21.26K to 17.36K | |
| 25-Jun-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 25-Jun-24 | Sale (Planned) | 9,207 | $161.62 | $1,487,990.00 | (35%) 26.34K to 17.13K | |
| 25-Jun-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 24-Jun-24 | Planned Option Sale | 6,250 | $163.08 | $1,019,230.00 | (21%) 29.12K to 22.87K | |
| 25-Jun-24 8:00 PM View: | Murray Dallan Chief Customer Officer | AVI Biopharma, Inc. (SRPT) | 24-Jun-24 | Payment of Exercise | 2,352 | $164.64 | $387,233.00 | (10%) 24.38K to 22.02K | |
| 25-Jun-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 24-Jun-24 | Payment of Exercise | 2,483 | $164.64 | $408,801.00 | (6%) 42.41K to 39.93K | |
| 25-Jun-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 24-Jun-24 | Payment of Exercise | 2,352 | $164.64 | $387,233.00 | (7%) 31.47K to 29.12K | |
| 25-Jun-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 24-Jun-24 | Sale (Planned) | 1,609 | $163.08 | $262,391.00 | (7%) 22.87K to 21.26K | |
| 25-Jun-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 24-Jun-24 | Payment of Exercise | 2,352 | $164.64 | $387,233.00 | (7%) 34.94K to 32.59K | |
| 25-Jun-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 24-Jun-24 | Payment of Exercise | 2,182 | $164.64 | $359,244.00 | (3%) 74.32K to 72.14K | |
| 25-Jun-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 21-Jun-24 | Option Exercise | 6,250 | -- | -- | 9% 68.07K to 74.32K | |
| 25-Jun-24 8:00 PM View: | Murray Dallan Chief Customer Officer | AVI Biopharma, Inc. (SRPT) | 21-Jun-24 | Option Exercise | 6,250 | -- | -- | 34% 18.13K to 24.38K | |
| 25-Jun-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 21-Jun-24 | Option Exercise | 6,250 | -- | -- | 17% 36.16K to 42.41K | |
| 25-Jun-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 21-Jun-24 | Option Exercise | 6,250 | -- | -- | 25% 25.22K to 31.47K | |
| 25-Jun-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 21-Jun-24 | Option Exercise | 6,250 | -- | -- | 22% 28.69K to 34.94K | |
| 11-Mar-24 8:00 PM View: | Boor Kathryn Jean Director | AVI Biopharma, Inc. (SRPT) | 11-Mar-24 | Private Sale | 761 | $122.93 | $93,549.70 | (9%) 8.28K to 7.52K | |
| 11-Mar-24 8:02 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Option Sale | 15,000 | $123.25 | $1,848,800.00 | (40%) 37.84K to 22.84K | |
| 11-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 909 | $123.14 | $111,934.00 | (1%) 68.98K to 68.07K | |
| 11-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 1,035 | $123.14 | $127,450.00 | (3%) 37.2K to 36.16K | |
| 11-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 472 | $123.14 | $58,122.10 | (2%) 25.69K to 25.22K | |
| 11-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Payment of Exercise | 899 | $123.14 | $110,703.00 | (3%) 29.59K to 28.69K | |
| 11-Mar-24 8:02 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 08-Mar-24 | Option Exercise | 15,000 | $13.90 | $208,500.00 | 66% 22.84K to 37.84K | |
| 11-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 512 | $120.49 | $61,690.90 | (< 1%) 69.49K to 68.98K | |
| 11-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 526 | $120.49 | $63,377.70 | (1%) 37.73K to 37.2K | |
| 11-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 506 | $120.49 | $60,967.90 | (2%) 26.2K to 25.69K | |
| 11-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 07-Mar-24 | Payment of Exercise | 506 | $120.49 | $60,967.90 | (2%) 30.09K to 29.59K | |
| 06-Mar-24 10:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 1,389 | $125.32 | $174,069.00 | (4%) 39.11K to 37.73K | |
| 06-Mar-24 10:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 522 | $125.32 | $65,417.00 | (2%) 26.72K to 26.2K | |
| 06-Mar-24 10:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 1,734 | $125.32 | $217,305.00 | (5%) 31.83K to 30.09K | |
| 06-Mar-24 10:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 04-Mar-24 | Payment of Exercise | 1,728 | $125.32 | $216,553.00 | (2%) 71.22K to 69.49K | |
| 05-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 26% 23.09K to 29.09K | |
| 05-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Sale | 1,200 | $128.30 | $153,960.00 | (3%) 40.31K to 39.11K | |
| 05-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 9% 66.0K to 72.0K | |
| 05-Mar-24 8:00 PM View: | Arif Bilal Chief Tech Ops Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Sale | 2,000 | $128.84 | $257,676.00 | (7%) 28.72K to 26.72K | |
| 05-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Sale | 2,000 | $125.34 | $250,680.00 | (6%) 33.83K to 31.83K | |
| 05-Mar-24 8:00 PM View: | Chambers Michael Andrew Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | < 1% 253.43K to 255.27K | |
| 05-Mar-24 8:00 PM View: | Mayo Stephen Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | 23% 7.91K to 9.76K | |
| 05-Mar-24 8:00 PM View: | Estepan Ian Michael Chief Financial Officer | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 17% 34.68K to 40.68K | |
| 05-Mar-24 8:00 PM View: | Rodino-Klapac Louise Head of R&D, CSO | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Payment of Exercise | 778 | $126.19 | $98,175.80 | (1%) 72.0K to 71.22K | |
| 05-Mar-24 8:00 PM View: | Behrens M Kathleen Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | < 1% 184.99K to 186.84K | |
| 05-Mar-24 8:00 PM View: | Brown Ryan Edward EVP, General Counsel | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 6,000 | -- | -- | 21% 28.1K to 34.1K | |
| 05-Mar-24 8:00 PM View: | Wigzell Hans Lennart Rudolf Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | 9% 20.99K to 22.84K | |
| 05-Mar-24 8:00 PM View: | Boor Kathryn Jean Director | AVI Biopharma, Inc. (SRPT) | 01-Mar-24 | Grant | 1,846 | -- | -- | 29% 6.43K to 8.28K |
